265 related articles for article (PubMed ID: 26063896)
1. International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013).
Amoroso V; Generali D; Buchholz T; Cristofanilli M; Pedersini R; Curigliano G; Daidone MG; Di Cosimo S; Dowsett M; Fox S; Harris AL; Makris A; Vassalli L; Ravelli A; Cappelletti MR; Hatzis C; Hudis CA; Pedrazzoli P; Sapino A; Semiglazov V; Von Minckwitz G; Simoncini EL; Jacobs MA; Barry P; Kühn T; Darby S; Hermelink K; Symmans F; Gennari A; Schiavon G; Dogliotti L; Berruti A; Bottini A
J Natl Cancer Inst Monogr; 2015 May; 2015(51):90-6. PubMed ID: 26063896
[TBL] [Abstract][Full Text] [Related]
2. International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010).
Berruti A; Generali D; Kaufmann M; Puztai L; Curigliano G; Aglietta M; Gianni L; Miller WR; Untch M; Sotiriou C; Daidone M; Conte P; Kennedy D; Damia G; Petronini P; Di Cosimo S; Bruzzi P; Dowsett M; Desmedt C; Mansel RE; Olivetti L; Tondini C; Sapino A; Fenaroli P; Tortora G; Thorne H; Bertolini F; Ferrozzi F; Danova M; Tagliabue E; de Azambuja E; Makris A; Tampellini M; Dontu G; Van't Veer L; Harris AL; Fox SB; Dogliotti L; Bottini A
J Natl Cancer Inst Monogr; 2011; 2011(43):147-51. PubMed ID: 22043063
[TBL] [Abstract][Full Text] [Related]
3. [Neoadjuvant systemic therapy for breast cancer].
Semiglazov VF
Vopr Onkol; 2015; 61(2):162-8. PubMed ID: 26087591
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant Model for Testing Emerging Targeted Therapies in Breast Cancer.
Esposito A; Criscitiello C; Curigliano G
J Natl Cancer Inst Monogr; 2015 May; 2015(51):51-5. PubMed ID: 26063887
[TBL] [Abstract][Full Text] [Related]
5. Management of the axilla after neoadjuvant chemotherapy for clinically node positive breast cancer: A nationwide survey study in The Netherlands.
Vugts G; Maaskant-Braat AJ; de Roos WK; Voogd AC; Nieuwenhuijzen GA
Eur J Surg Oncol; 2016 Jul; 42(7):956-64. PubMed ID: 27107791
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant or adjuvant chemotherapy in early breast cancer?
Montemurro F; Nuzzolese I; Ponzone R
Expert Opin Pharmacother; 2020 Jun; 21(9):1071-1082. PubMed ID: 32237920
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation.
Newman EA; Sabel MS; Nees AV; Schott A; Diehl KM; Cimmino VM; Chang AE; Kleer C; Hayes DF; Newman LA
Ann Surg Oncol; 2007 Oct; 14(10):2946-52. PubMed ID: 17514407
[TBL] [Abstract][Full Text] [Related]
8. Preoperative (neoadjuvant) systemic treatment of breast cancer.
Kaufmann M; von Minckwitz G; Rody A
Breast; 2005 Dec; 14(6):576-81. PubMed ID: 16199160
[TBL] [Abstract][Full Text] [Related]
9. Primary systemic therapy of breast cancer.
Sachelarie I; Grossbard ML; Chadha M; Feldman S; Ghesani M; Blum RH
Oncologist; 2006 Jun; 11(6):574-89. PubMed ID: 16794237
[TBL] [Abstract][Full Text] [Related]
10. Better predictive value of axillary lymph node (ALN) status after systemic therapy for operable HER2-overexpressing breast cancer: A single-institution retrospective study.
Zhang Y; Mo M; Li JW; Zhou Y; Wu J; Yu KD; Shen ZZ; Shao ZM; Liu GY
Eur J Surg Oncol; 2016 Aug; 42(8):1146-52. PubMed ID: 27365197
[TBL] [Abstract][Full Text] [Related]
11. Patterns of Failure in Women Who Have Residual Nodal Disease After Neoadjuvant Chemotherapy for Breast Cancer According to Extent of Lymph Node Surgery.
Kozak MM; Horst KC; Gutkin PM; Jacobson CE; Walck E; von Eyben R; Dirbas FM
Clin Breast Cancer; 2020 Oct; 20(5):431-438. PubMed ID: 32522481
[TBL] [Abstract][Full Text] [Related]
12. [The feasibility and the role of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].
Péley G; Török K; Farkas E; Mátrai Z; Horváth Z; Sinkovics I; Hitre E; Rényi-Vámos F; Orosz Z; Köves I
Magy Onkol; 2006; 50(1):19-23. PubMed ID: 16617379
[TBL] [Abstract][Full Text] [Related]
13. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy.
Kuerer HM; Sahin AA; Hunt KK; Newman LA; Breslin TM; Ames FC; Ross MI; Buzdar AU; Hortobagyi GN; Singletary SE
Ann Surg; 1999 Jul; 230(1):72-8. PubMed ID: 10400039
[TBL] [Abstract][Full Text] [Related]
14. [Sentinel lymph node biopsy and neoadjuvant treatment in breast cancer].
Duraes M; Guillot E; Seror J; Pouget N; Rouzier R
Bull Cancer; 2017 Oct; 104(10):892-901. PubMed ID: 28890124
[TBL] [Abstract][Full Text] [Related]
15. Current and future role of neoadjuvant therapy for breast cancer.
Untch M; Konecny GE; Paepke S; von Minckwitz G
Breast; 2014 Oct; 23(5):526-37. PubMed ID: 25034931
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy and timing of sentinel lymph node biopsy in different molecular subtypes of breast cancer with clinically negative axilla.
Bi Z; Liu J; Chen P; Liu Y; Zhao T; Wang C; Zhang Z; Sun X; Qiu P; Cong B; Song X; Wang Y
Breast Cancer; 2019 May; 26(3):373-377. PubMed ID: 30666563
[TBL] [Abstract][Full Text] [Related]
17. De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study.
Simons JM; Koppert LB; Luiten EJT; van der Pol CC; Samiei S; de Wilt JHW; Siesling S; Smidt ML
Breast Cancer Res Treat; 2020 Apr; 180(3):725-733. PubMed ID: 32180074
[TBL] [Abstract][Full Text] [Related]
18. Impact of Neoadjuvant Versus Adjuvant Chemotherapy on the Extent of Axillary Surgery for Clinically Node-Negative Breast Cancers of Triple-Negative and HER2-Overexpressing Phenotypes.
Thompson JL; Wrubel E; Davis AT; Koehler T; Chung MH; Wright GP
Clin Breast Cancer; 2020 Oct; 20(5):390-394. PubMed ID: 32444317
[TBL] [Abstract][Full Text] [Related]
19. [Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].
Mátrai Z; Tóth L; Polgár C; Láng I; Gõdény M; Sinkovics I; Horváth Z; Bidlek M; Udvarhelyi N; Bartal A; Sávolt A; Ujhelyi M; Kásler M
Magy Onkol; 2011 Jun; 55(2):73-84. PubMed ID: 21655472
[TBL] [Abstract][Full Text] [Related]
20. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.
Kuehn T; Bauerfeind I; Fehm T; Fleige B; Hausschild M; Helms G; Lebeau A; Liedtke C; von Minckwitz G; Nekljudova V; Schmatloch S; Schrenk P; Staebler A; Untch M
Lancet Oncol; 2013 Jun; 14(7):609-18. PubMed ID: 23683750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]